Efficacy of Axitinib After Nivolumab Failure in Metastatic Renal Cell Carcinoma

Background/Aim: Whether molecular-targeted therapy, particularly axitinib, is effective after failure of immune checkpoint inhibitors in metastatic renal cell carcinoma (mRCC) remains unclear. Here, we evaluated the therapeutic effect of axitinib as a third-line therapy following second-line nivolum...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:In Vivo
Hauptverfasser: ISHIHARA, HIROKI, TAKAGI, TOSHIO, KONDO, TSUNENORI, FUKUDA, HIRONORI, TACHIBANA, HIDEKAZU, YOSHIDA, KAZUHIKO, IIZUKA, JUNPEI, OKUMI, MASAYOSHI, ISHIDA, HIDEKI, TANABE, KAZUNARI
Format: Artigo
Sprache:Inglês
Veröffentlicht: International Institute of Anticancer Research 2020
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7279840/
https://ncbi.nlm.nih.gov/pubmed/32354960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11943
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge